Aarey Drugs and Pharmaceuticals Share Price Target 2026: Expert Forecast, Catalysts and Key Risks
- May 13, 2026
- Posted by: Neeraj Pandey
- Category: News
The Aarey Drugs and Pharmaceuticals share price target for 2026 stands at Rs 81.6 as per analyst estimates, implying approximately 20 percent upside from the current market price of Rs 68. Investors tracking the Aarey Drugs and Pharmaceuticals share price target 2026 need to understand the full picture including FY27 earnings catalysts, sector tailwinds, key risks, and the bull versus bear case scenarios. The Aarey Drugs and Pharmaceuticals share price target thesis is backed by the company’s industry position, strategic initiatives, and improving macro conditions. This article covers every dimension of the Aarey Drugs and Pharmaceuticals share price target updated May 2026.
Click Here – Get Free Investment Predictions
Aarey Drugs and Pharmaceuticals Company Overview
Aarey Drugs and Pharmaceuticals (NSE: AAREYDRUGS) is a pharma manufacturer producing APIs, bulk drugs, and specialty chemicals including Metronidazole, Mefenamic Acid, and Doxofylline for domestic and export markets. At CMP Rs 68 against a 52 week range of Rs 31.35 to Rs 100, the stock currently trades at a meaningful discount to its 52 week high, creating a re-rating opportunity for investors tracking the Aarey Drugs and Pharmaceuticals share price target of Rs 81.6. The company’s market capitalisation stands at Rs 190 crore.
| Parameter | Value |
|---|---|
| NSE Ticker | AAREYDRUGS |
| Sector | Pharmaceuticals |
| CMP May 2026 | Rs 68 |
| 52 Week High | Rs 100 |
| 52 Week Low | Rs 31.35 |
| Market Cap | Rs 190 crore |
| Trailing P/E | 52x |
| 12M Analyst Target | Rs 81.6 |
| Bull Case Target | Rs 98.6 |
| Bear Case Target | Rs 54.4 |
Why Is Aarey Drugs and Pharmaceuticals Share Price Target Set at Rs 81.6 for 2026
FY27 Earnings Delivery and Revenue Acceleration
FY27 is the pivotal year for the earnings recovery thesis underpinning the Aarey Drugs and Pharmaceuticals share price target 2026 of Rs 81.6. Analysts project 15 to 20 percent PAT growth in FY27 as operational leverage and strategic investments begin contributing to the top line. Q4 FY26 results with positive FY27 guidance are the immediate trigger for re-rating toward the Aarey Drugs and Pharmaceuticals share price target forecast. This FY27 earnings delivery is the primary variable that bridges the current CMP of Rs 68 with the Aarey Drugs and Pharmaceuticals share price target of Rs 81.6.
Structural Sector Tailwinds in Pharmaceuticals
India’s pharmaceutical sector is growing on the back of rising healthcare expenditure, USFDA approvals, and expanding generic drug export markets globally. Aarey Drugs and Pharmaceuticals’s market position and operational expertise create a compounding growth runway that directly supports the Aarey Drugs and Pharmaceuticals share price target consensus of Rs 81.6. Improving sectoral fundamentals are expected to accelerate earnings momentum through FY27, reinforcing the Aarey Drugs and Pharmaceuticals share price target 2026 bull case of Rs 98.6.
RBI Rate Cut Cycle and Lower Cost of Capital
The RBI rate cut cycle which commenced in early 2026 reduces Aarey Drugs and Pharmaceuticals’s borrowing costs and stimulates demand across its end markets. Lower interest costs improve EBITDA to PAT conversion, directly expanding EPS and supporting the Aarey Drugs and Pharmaceuticals share price target 2026 of Rs 81.6. Any further rate cuts through FY27 compound this benefit and add upside optionality toward the bull case Aarey Drugs and Pharmaceuticals share price target of Rs 98.6.
Union Budget 2026 Policy Support
Union Budget 2026-27’s Rs 11.21 lakh crore infrastructure capex, PLI scheme continuity, and consumption demand incentives create a positive policy backdrop for Aarey Drugs and Pharmaceuticals’s Pharmaceuticals business. These policy tailwinds directly support the Aarey Drugs and Pharmaceuticals share price target 2026 bull case and improve the probability of achieving the Rs 81.6 analyst estimate over the next 12 months.
Improving FII Flows Post US Tariff Shock
As macro conditions normalise post the April 2026 US tariff shock, FII flows into quality Indian companies are expected to recover through FY27, directly supporting the Aarey Drugs and Pharmaceuticals share price target of Rs 81.6. Aarey Drugs and Pharmaceuticals’s valuation at 52x P/E relative to sector peers positions it as a potential beneficiary of institutional reallocation as sentiment normalises across Indian equities.
Screen the best stocks on the Univest Screener.
Aarey Drugs and Pharmaceuticals Share Price Targets: Short Term, 12 Month, and Long Term
Short Term Target: 3 to 6 Months
The short term Aarey Drugs and Pharmaceuticals share price target is anchored to the 52 week low support zone near Rs 31.35. In the 3 to 6 month timeframe, a recovery toward 10 to 15 percent above current levels is the base case if Q4 FY26 results confirm the earnings recovery trajectory. Any positive operational update could serve as a near-term re-rating trigger toward the full Aarey Drugs and Pharmaceuticals share price target 2026 of Rs 81.6.
12 Month Aarey Drugs and Pharmaceuticals Share Price Target 2026
The 12 month Aarey Drugs and Pharmaceuticals share price target 2026 is Rs 81.6, implying approximately 20 percent upside from CMP Rs 68. This base case assumes in-line FY27 earnings delivery, partial normalisation of FII flows, and continued execution on strategic priorities. Track the live Aarey Drugs and Pharmaceuticals share price target data on NSE ticker AAREYDRUGS.
Long Term Target: FY27 to FY28
For investors with a 2 to 3 year horizon, the long term Aarey Drugs and Pharmaceuticals share price target is Rs 98.6 in the bull case. Full FY27-FY28 earnings delivery, strategic expansion, and sector re-rating toward higher peer multiples are the conditions required. The long-term Aarey Drugs and Pharmaceuticals share price target thesis rests on Aarey Drugs and Pharmaceuticals’s market leadership and expanding addressable opportunity in the Pharmaceuticals space.
Bull Case and Bear Case for Aarey Drugs and Pharmaceuticals Share Price Target
Bull Case Aarey Drugs and Pharmaceuticals Share Price Target Rs 98.6
The bull case for the Aarey Drugs and Pharmaceuticals share price target of Rs 98.6 materialises if FY27 earnings exceed analyst estimates, sector tailwinds accelerate beyond consensus, and FII flows return to quality Indian names. Under this scenario, the stock re-rates toward higher earnings multiples, making the Aarey Drugs and Pharmaceuticals share price target of Rs 98.6 achievable within FY27 to FY28.
Bear Case Aarey Drugs and Pharmaceuticals Share Price Target Rs 54.4
The bear case sees the Aarey Drugs and Pharmaceuticals share price target testing Rs 54.4 if FY27 earnings guidance disappoints and FII outflows from Indian equities persist. At Rs 54.4, the stock would revisit near the 52 week low support zone of Rs 31.35, requiring a full reassessment of the Aarey Drugs and Pharmaceuticals share price target thesis before fresh targets can be assigned.
| Scenario | Price Target | Conditions |
|---|---|---|
| Bull Case | Rs 98.6 | FY27 earnings beat, sector re-rating, FII inflows, macro normalisation |
| Base Case Analyst Forecast | Rs 81.6 | In-line FY27 delivery, partial FII recovery, steady execution |
| Bear Case | Rs 54.4 | FY27 guidance cut, earnings miss, persistent FII outflows |
Key Risks to the Aarey Drugs and Pharmaceuticals Share Price Target 2026
US Tariff Macro Headwind
The 26 percent US reciprocal tariff announced April 2, 2026 created FII outflow pressure across Indian equities including Aarey Drugs and Pharmaceuticals. Prolonged trade tension or global demand slowdown remains a key downside risk to the Aarey Drugs and Pharmaceuticals share price target 2026 of Rs 81.6.
Valuation and Earnings Miss Risk
At 52x P/E, any FY27 earnings miss or guidance cut could trigger multiple compression, posing the most immediate risk to the Aarey Drugs and Pharmaceuticals share price target 2026 of Rs 81.6. Investors should monitor quarterly results closely for confirmation of the earnings recovery trajectory.
Competitive Pressure in Pharmaceuticals
Intensifying competition in the Pharmaceuticals space could compress Aarey Drugs and Pharmaceuticals’s pricing power and market share over the medium term. This is a structural risk that investors should weigh when evaluating the Aarey Drugs and Pharmaceuticals share price target of Rs 81.6 at current levels.
FII Selling Pressure and Liquidity Risk
Global risk-off events can trigger institutional selling, disconnecting price from fundamental value. Sustained FII outflows could delay re-rating toward the Aarey Drugs and Pharmaceuticals share price target regardless of company-level improvement through FY27.
How to Invest in Aarey Drugs and Pharmaceuticals
- Research the Fundamentals: Analyse Aarey Drugs and Pharmaceuticals’s quarterly results, balance sheet, and strategic developments before making any investment decision based on the Aarey Drugs and Pharmaceuticals share price target 2026 of Rs 81.6.
- Open a Demat Account: Buy Aarey Drugs and Pharmaceuticals (NSE: AAREYDRUGS) through any SEBI registered broker to invest with full regulatory protection.
- Plan Your Entry: Key support is near Rs 31.35 at the 52 week low. A confirmed FY27 earnings uptick would strengthen the entry case toward the Aarey Drugs and Pharmaceuticals share price target of Rs 81.6.
- Position Sizing: Allocate a maximum of 3 to 5 percent of your portfolio to any single stock to manage concentration and liquidity risk effectively.
- Consult a SEBI Registered Advisor: Always seek guidance from a SEBI registered financial advisor before investing based on any Aarey Drugs and Pharmaceuticals share price target estimate. SEBI Registration No. INH000013776.
Download the Univest iOS App or the Univest Android App to get daily stock recommendations and expert research.
FAQs on Aarey Drugs and Pharmaceuticals Share Price Target 2026
What is the Aarey Drugs and Pharmaceuticals share price target for 2026?
The Aarey Drugs and Pharmaceuticals share price target 2026 is Rs 81.6 based on analyst estimates, implying approximately 20 percent upside from the current CMP of Rs 68. The bull case is Rs 98.6 and the bear case is Rs 54.4.
Is Aarey Drugs and Pharmaceuticals a good buy at CMP Rs 68?
At Rs 68, the stock offers potential upside to the Aarey Drugs and Pharmaceuticals share price target 2026 of Rs 81.6 if FY27 earnings recover as projected. Investment suitability depends on individual risk tolerance and time horizon. Consult a SEBI registered financial advisor before investing.
What is the 52 week high and low of Aarey Drugs and Pharmaceuticals?
The 52 week high of Aarey Drugs and Pharmaceuticals is Rs 100 and the 52 week low is Rs 31.35. At CMP Rs 68, the stock is below its 52 week peak, creating upside potential to the Aarey Drugs and Pharmaceuticals share price target 2026 of Rs 81.6.
What are the main risks to the Aarey Drugs and Pharmaceuticals share price target?
Key risks to the Aarey Drugs and Pharmaceuticals share price target of Rs 81.6 include US tariff-driven FII selling, earnings miss risk, competitive pressure in Pharmaceuticals, and broader market volatility. Monitor quarterly results for confirmation of the recovery trajectory.
What are the key catalysts for the Aarey Drugs and Pharmaceuticals share price target?
Primary catalysts for the Aarey Drugs and Pharmaceuticals share price target 2026 include FY27 PAT recovery, sector tailwinds in Pharmaceuticals, RBI rate cut support, Budget policy uplift, and FII flow normalisation into quality Indian equities through FY27.
Where can I track Aarey Drugs and Pharmaceuticals live price and analyst data?
Track the Aarey Drugs and Pharmaceuticals share price target and live price on NSE (ticker: AAREYDRUGS). Financial data platforms provide quarterly results, margins, and peer comparisons to assess the Rs 81.6 analyst estimate thesis in real time.
What is the Aarey Drugs and Pharmaceuticals share price target for 2027?
For FY27 to FY28, the long term Aarey Drugs and Pharmaceuticals share price target is Rs 98.6 in the bull case, assuming earnings acceleration, sector re-rating, and FII flow recovery. Consult a SEBI registered financial advisor for personalised investment guidance.
How can I buy Aarey Drugs and Pharmaceuticals shares?
You can buy Aarey Drugs and Pharmaceuticals (NSE: AAREYDRUGS) through any SEBI registered stockbroker by opening a Demat and trading account online. Research the Aarey Drugs and Pharmaceuticals share price target on verified financial platforms and always set a disciplined entry, target, and stop loss before investing.
Investments in securities are subject to market risk. This content is for educational purposes only and does not constitute investment advice. All analyst targets are estimates based on publicly available data as of May 2026. Consult a SEBI registered financial advisor before investing. SEBI Registration No. INH000013776.
